NMR Studies of Tau Protein in Tauopathies
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14740%2F21%3A00123604" target="_blank" >RIV/00216224:14740/21:00123604 - isvavai.cz</a>
Result on the web
<a href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.761227/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fmolb.2021.761227/full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fmolb.2021.761227" target="_blank" >10.3389/fmolb.2021.761227</a>
Alternative languages
Result language
angličtina
Original language name
NMR Studies of Tau Protein in Tauopathies
Original language description
Tauopathies, including Alzheimer's disease (AD), are the most troublesome of all age-related chronic conditions, as there are no well-established disease-modifying therapies for their prevention and treatment. Spatio-temporal distribution of tau protein pathology correlates with cognitive decline and severity of the disease, therefore, tau protein has become an appealing target for therapy. Current knowledge of the pathological effects and significance of specific species in the tau aggregation pathway is incomplete although more and more structural and mechanistic insights are being gained using biophysical techniques. Here, we review the application of NMR to structural studies of various tau forms that appear in its aggregation process, focusing on results obtained from solid-state NMR. Furthermore, we discuss implications from these studies and their prospective contribution to the development of new tauopathy therapies.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
<a href="/en/project/LTAUSA18168" target="_blank" >LTAUSA18168: Selective NMR labelling as a tool for characterization of protein complexes involved in neurodegenerative diseases.</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Frontiers in Molecular Biosciences
ISSN
2296-889X
e-ISSN
—
Volume of the periodical
8
Issue of the periodical within the volume
NOV
Country of publishing house
CH - SWITZERLAND
Number of pages
16
Pages from-to
761227
UT code for WoS article
000727903000001
EID of the result in the Scopus database
2-s2.0-85120688263